Orthofix Reports Second Quarter 2023 Results and Raises Revenue and Adjusted EBITDA Guidance
Net sales of $187.0 million, an increase of 58% on a reported basis and 7% on a pro forma constant currency basis over prior year Bone Growth Therapies growth of 10%, marking two consecutive...